Converge Bio vs Insitro
Converge Bio vs Insitro, compared side by side on 22 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Converge Bio is on 56/100 and Insitro on 62/100.
Where each one leads
Converge Bio
- headcount growth: +220.3% against +10.9%
Insitro
- our overall score: 62/100 against 56/100
- domain rating: 64/100 against 28/100
- headcount: 255 against 51
- funding raised: $243M against $5.5M
- LinkedIn following: 42,173 against 6,830
At a glance
| Measure | Converge Bio | Insitro |
|---|---|---|
| What it is | Computational platform using LLMs trained on biological and chemical data for drug discovery. | Data-driven drug discovery and development company using machine learning and high-throughput biology. |
| Category | Life Sciences, Generative AI, Large Language Models (LLMs), Pharmaceutical | Healthcare, Drug Discovery, Drug Development, DNA |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2023 | 2018 |
| Headquarters | San Francisco, United States | South San Francisco, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Converge Bio | Insitro |
|---|---|---|
| Employees | 51 | 255 |
| Headcount growthLast 12 months | +220.3% | +10.9% |
| Total funding | $5.5M | $243M |
| Latest round | Seed | Series B |
| Valuation | Not published | $7.0B |
| LinkedIn followers | 6,830 | 42,173 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Converge Bio | Insitro |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 56/100 | 62/100 |
| Traction | 51/100 | 60/100 |
| Team | 70/100 | 50/100 |
| Community | Not published | 8/100 |
| Search visibility | 36/100 | 62/100 |
| Quality | 62/100 | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (44/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 28/100 | 64/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Converge Bio | Insitro |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | Framer | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Google Tag Manager, Microsoft Clarity | Not detected |
| Open source | Yes | No |
| Self-hostable | Yes | No |
Converge Bio vs Insitro: common questions
Which is better, Converge Bio or Insitro?
On our 0-100 score Insitro rates higher (62/100 against 56/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 22 data points above: read the rows that match what you are buying for.
How do Converge Bio and Insitro compare on the numbers?
Converge Bio leads on headcount growth (+220.3% against +10.9%). Insitro leads on our overall score (62/100 against 56/100), domain rating (64/100 against 28/100), headcount (255 against 51), funding raised ($243M against $5.5M), LinkedIn following (42,173 against 6,830).
Read the full Converge Bio review and pricing or the Insitro review and pricing. You can also browse other Converge Bio alternatives we track.